Sign Up Today and Learn More About Datavant Stock
Invest in or calculate the value of your shares in Datavant or other pre-IPO companies through EquityZen's platform.
About Datavant Stock
Founded
2017
Headquarters
San Francisco, CA, US
Industries
Software, Data and Analytics, Science and Engineering
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and sharing health data. The platform that the company offers organizes healthcare data for use in clinical trial decision-making. Its focus is on the employment of artificial intelligence to improve the clinical trial process and to improve the design and interpretation of clinical trials, helping pharmaceutical companies to manage the privacy, security, compliance, and trust required to enable safe data sharing. Travis May established Datavant in San Francisco, California in 2017.
Datavant Press Mentions
Stay in the know about the latest news on Datavant
Avante Launches the First AI-Native Benefits Intelligence Platform, Helping Employers Reduce Their Second-Largest Expense
techrseries • Apr 08, 2025
Uncertainty the word as companies watch US tariff plans
rte • Apr 07, 2025
How To Hire a Platform Engineer
thenewstack • Apr 02, 2025
Datavant announces R&D centre in Galway with 125 new jobs
siliconrepublic • Apr 01, 2025
US medical data company Datavant sets up R&D centre in Galway
irishexaminer • Apr 01, 2025
Investors in Datavant
Discover investors in Datavant stock and explore their portfolio companies
Datavant Management
Leadership team at Datavant
Chief Executive Officer
Travis May
Chief Financial Officer
Mike Burwell
Join now and verify your accreditation status to gain access to:
- Datavant Current Valuation
- Datavant Stock Price
- Datavant Management
- Available deals in Datavant and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Datavant Cap Table and Funding History by Share Class and Liquidity Preferences
- Datavant Revenue and Financials
- Datavant Highlights
- Datavant Business Model
- Datavant Risk Factors
- Datavant Research Report from SACRA Research
Trading Datavant Stock
How to invest in Datavant stock?
Accredited investors can buy pre-IPO stock in companies like Datavant through EquityZen funds. These investments are made available by existing Datavant shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Datavant stock?
Shareholders can sell their Datavant stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
